Giandomenico Roviello (G Roviello)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Ospedale San Donato

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ospedale San Donato Sep 01 2016

Italy

Borsista di ricerca :: Oncologia

Università degli Studi di Brescia Centro di Studio e di Ricerca di Bioetica Sep 01 2015 - Aug 31 2016

Italy

Assegnista di Ricerca

Publications

Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza, Giuseppina Gallucci, Geppino Falco, Giandomenico Roviello, Anna Maria Bochicchio
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. Diseases (Basel, Switzerland) 12 (3) (2024)
Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza, Giuseppina Gallucci, Geppino Falco, Giandomenico Roviello, Anna Maria Bochicchio
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. Diseases (Basel, Switzerland) 12 (3) (2024)
Alessandra Damassi, Malvina Cremante, Alessio Signori, Sara Elena Rebuzzi, Andrea Malgeri, Marilena Di Napoli, Orazio Caffo, Francesca Vignani, Alessia Cavo, Giandomenico Roviello, Veronica Prati, Marianna Tudini, Francesco Atzori, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nolè, Fabio Catalano, Veronica Murianni, Pasquale Rescigno, Giuseppe Luigi Banna, Giuseppe Fornarini, Sebastiano Buti
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab. Immunotherapy (2024)
Francesco Bloise, Fiorella Manfredi, Luca Zatteri, Giovanni Dima, Chiara Carli, Rosanna Di Vita, Maria Olivieri, Enrico Sammarco, Marco Ferrari, Alessia Salfi, Adele Bonato, Debora Serafin, Natalia Coccia, Laura Doni, Luca Galli, Michele Sisani, Giandomenico Roviello, Martina Catalano, Federico Paolieri
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm. Cells 13 (11) (2024)
Giandomenico Roviello, Matteo Santoni, Guru P Sonpavde, Martina Catalano
The evolving treatment landscape of metastatic urothelial cancer. Nature reviews. Urology (2024)
Francesco Bloise, Fiorella Manfredi, Luca Zatteri, Giovanni Dima, Chiara Carli, Rosanna Di Vita, Maria Olivieri, Enrico Sammarco, Marco Ferrari, Alessia Salfi, Adele Bonato, Debora Serafin, Natalia Coccia, Laura Doni, Luca Galli, Michele Sisani, Giandomenico Roviello, Martina Catalano, Federico Paolieri
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm. Cells 13 (11) (2024)
Francesco Bloise, Fiorella Manfredi, Luca Zatteri, Giovanni Dima, Chiara Carli, Rosanna Di Vita, Maria Olivieri, Enrico Sammarco, Marco Ferrari, Alessia Salfi, Adele Bonato, Debora Serafin, Natalia Coccia, Laura Doni, Luca Galli, Michele Sisani, Giandomenico Roviello, Martina Catalano, Federico Paolieri
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm. Cells 13 (11) (2024)
Simona Laurino, Sabino Russi, Ludmila Carmen Omer, Alberto D'Angelo, Giovanni Bozza, Giuseppina Gallucci, Geppino Falco, Giandomenico Roviello, Anna Maria Bochicchio
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. Diseases (Basel, Switzerland) 12 (3) (2024)
Martina Catalano, Giandomenico Roviello, Giuseppe Aprile, Monica Ramello, Raffaele Conca, Roberto Petrioli, Gabriele Perrone, Anna Ianza, Enrico Mini
Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer. Future oncology (London, England) (2023)
Gabriele Perrone, Luigi Rigacci, Sara Urru, Sofya Kovalchuk, Marco Brugia, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo, Silvia Birtolo, Alessandro Melosi, Simone Santini, Ida Landini, Giandomenico Roviello, Raffaella Santi, Alessandra Macciotta, Fulvio Ricceri, Alberto Bosi, Monica Bocchia, Mario Petrini, Enrico Mini, Stefania Nobili
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma. Cancers 15 (10) (2023)
Martina Catalano, Gabriella Nesi, Giandomenico Roviello
Tumor microenvironment in renal cell carcinoma: what is the current impact? Future oncology (London, England) (2023)
Martina Catalano, Daniele Lavacchi, Elisa Giommoni, Sonia Shabani, Alessia Guidolin, Marco Brugia, Roberto Petrioli, Monica Ramello, Serena Pillozzi, Lorenzo Antonuzzo, Giandomenico Roviello
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI. Future oncology (London, England) (2023)
Valeria Emma Palmieri, Giandomenico Roviello, Martina Catalano, Alberto D'Angelo, Gianmarco Vannini, Eleonora Buttitta, Enrico Mini
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature review. Immunotherapy 14 (7) (2022)
Giandomenico Roviello, Martina Catalano, Carlotta Ottanelli, Roberta Giorgione, Virginia Rossi, Elisabetta Gambale, Chiara Casadei, Ugo De Giorgi, Lorenzo Antonuzzo
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice. Medical oncology (Northwood, London, England) 39 (10) (2022)
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Giuseppe Fornarini, Sara Elena Rebuzzi, Umberto Basso, Davide Bimbatti, Laura Doni, Gabriella Nesi, Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, Luca Galli, Andrea Sbrana, Raffaele Conca, Claudia Carella, Emanuele Naglieri, Sandro Pignata, Giuseppe Procopio, Lorenzo Antonuzzo
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study. Cancer medicine 11 (16) (2022)
Giandomenico Roviello, Melissa Bersanelli, Martina Catalano
The latest developments in biomarkers predicting response to immunotherapy. Immunotherapy 14 (14) (2022)
Giandomenico Roviello, M Catalano, L F Iannone, L Marano, M Brugia, G Rossi, G Aprile, L Antonuzzo
Current status and future perspectives in HER2 positive advanced gastric cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (6) (2022)
Giandomenico Roviello, Alberto D'Angelo, Marianna Sirico, Matteo Pittacolo, Felipe Umpierre Conter, Navid Sobhani
Advances in anti-BRAF therapies for lung cancer. Investigational new drugs 39 (3) (2021)
Fausto Petrelli, Roberto Ferrara, Diego Signorelli, Antonio Ghidini, Claudia Proto, Raheleh Roudi, Mehrdad N Sabet, Sara Facelli, Marina C Garassino, Andrea Luciani, Giandomenico Roviello
Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis. Immunotherapy 13 (7) (2021)
Finn E von Eyben, Kalevi Kairemo, Channing J Paller, Manuela Andrea Hoffmann, Giovanni Paganelli, Irene Virgolini, Giandomenico Roviello
177Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Biomedicines 9 (8) (2021)
Giandomenico Roviello, Giuseppe Aprile, Alberto D'Angelo, Luigi Francesco Iannone, Franco Roviello, Karol Polom, Enrico Mini, Martina Catalano
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 24 (4) (2021)
Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, Alessia Mennitto, Carlo Messina, Chiara Airoldi, Gianmarco Vannini, Melissa Bersanelli
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism? Therapeutic advances in urology 13 (2021)
Ottavia Bernocchi, Marianna Sirico, Silvia Paola Corona, Carla Strina, Manuela Milani, Maria Rosa Cappelletti, Giuseppina Ferrero, Nicoletta Ziglioli, Valeria Cervoni, Andrea Macchiavelli, Giandomenico Roviello, Daniele Generali
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Sara Spinelli, Enrico Mini, Erminio Monteleone, Catia Angiolini, Giandomenico Roviello
ALTERTASTE: improving food pleasure and intake of oncology patients receiving chemotherapy. Future oncology (London, England) 17 (20) (2021)
Martina Catalano, Raffaele Conca, Roberto Petrioli, Monica Ramello, Giandomenico Roviello
FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer. Cancer management and research 12 (2020)
Giandomenico Roviello, Silvia Paola Corona, Alberto D'Angelo, Pietro Rosellini, Stefania Nobili, Enrico Mini
Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis. International journal of molecular sciences 21 (2) (2020)
Giandomenico Roviello, D Villari, R Roudi
Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)
Giandomenico Roviello, Andrea Casadei-Gardini, Stefania Nobili, Enrico Mini, Sara Fancelli
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment. Journal of oncology 2020 (2020)
Giandomenico Roviello, D Villari, G Nesi, B Detti
Radiotherapy after prostatectomy in high‑risk prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (11) (2020)
Alberto D'Angelo, Navid Sobhani, Robert Chapman, Stefan Bagby, Carlotta Bortoletti, Mirko Traversini, Katia Ferrari, Luca Voltolini, Jacob Darlow, Giandomenico Roviello
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies. Cancers 12 (11) (2020)
Giandomenico Roviello, F U Conter, E Mini, D Generali, M Traversini, D Lavacchi, S Nobili, N Sobhani
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer. Cancer chemotherapy and pharmacology 84 (4) (2019)
Massimiliano Salati, Roberto Filippi, Caterina Vivaldi, Francesco Caputo, Francesco Leone, Francesca Salani, Krisida Cerma, Massimo Aglietta, Lorenzo Fornaro, Elisa Sperti, Massimo Di Maio, Cinzia Ortega, Elisabetta Fenocchio, Pasquale Lombardi, Celeste Cagnazzo, Ilaria Depetris, Fabio Gelsomino, Andrea Spallanzani, Daniele Santini, Nicola Silvestris, Giuseppe Aprile, Giandomenico Roviello, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2019)
Giandomenico Roviello, Roberto Petrioli, Pietro Rosellini, Andrea Giovanni Multari, Raffaele Conca, Giovanni Paganini, Giorgio Chiriacò, Michele Aieta
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. Investigational new drugs 37 (3) (2019)
Giandomenico Roviello, Navid Sohbani, Roberto Petrioli, Maria Grazia Rodriquenz
Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy? Investigational new drugs 37 (6) (2019)
Giandomenico Roviello, M R Gatta Michelet, A D'Angelo, S Nobili, E Mini
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (7) (2019)
Giandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, Roberto Petrioli, Enrico Mini
Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights. Journal of oncology 2019 (2019)
Giandomenico Roviello, Silvia Paola Corona, Gabriella Nesi, Enrico Mini
Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter? Therapeutic advances in medical oncology 11 (2019)
Giandomenico Roviello, Roberto Petrioli, Alberto Bonetta, Raffaele Conca, Maria Grazia Rodriquenz, Michele Aieta
Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone. Investigational new drugs 36 (6) (2018)
Giandomenico Roviello, Daniele Generali
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis. Medical oncology (Northwood, London, England) 35 (3) (2018)
Navid Sobhani, Daniele Generali, Alberto D'Angelo, Michele Aieta, Giandomenico Roviello
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer. Investigational new drugs 36 (6) (2018)
Giandomenico Roviello, Silvia Paola Corona, Daniele Generali
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis. Medical oncology (Northwood, London, England) 34 (10) (2017)

Giandomenico Roviello.css-eqlu8i{font-size:small;padding-left:4px;} (G Roviello)

Publication Activity (10 Years)

Top Topics

Top Venues

Giandomenico Roviello (G Roviello)